Testing a device that reads fingerprints for drug screening
This trial tests a new drug screening system that reads fingerprints to detect drugs in the body. It will check if certain medications interfere with the device's accuracy, which may lead to faster and easier drug testing in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a healthy adult between 18 and 55 years old.
- Weigh at least 60 kg (about 132 pounds) and have a BMI between 18 and 35.
- Be able to read and communicate in English.
- Have all or most of your fingers on both hands.
- Not have a history of substance abuse or tobacco use in the last two weeks (with a few exceptions for smokers in the study).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a new fingerprint-based drug screening system to standard methods. Healthy volunteers will participate to help verify that the new fingerprint test works accurately for detecting drugs.
This trial tests a new drug called CAY001 in healthy volunteers to see how safe it is and how the body processes it. It may help researchers understand if the drug is safe enough to test in people with medical conditions later.
This study tests a new drug screening system by comparing how it works on healthy volunteers. You will provide a sample (like sweat or saliva) to see if the device can detect drugs accurately.
This study is testing a new device that measures blood sugar without a finger prick. It is open to healthy adults and people with type 2 diabetes, to see if the non-invasive meter works as well as standard blood tests.
This study tests a new medicine (BI 3776528) in healthy men to see how well different doses are tolerated. It helps researchers find the safest dose before testing in people with a condition.
This study tests a new medicine (INCA033989) given as a shot or IV in healthy adults to see how the body processes it and if it's safe.
Hear when a new Interference With Routine Analytical Tests trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.